InvestorsObserver
×
News Home

Is Tango Therapeutics Inc (TNGX) Stock at the Top of the Biotechnology Industry?

Monday, October 09, 2023 01:30 PM | InvestorsObserver Analysts

Mentioned in this article

Is Tango Therapeutics Inc (TNGX) Stock at the Top of the Biotechnology Industry?

The 81 rating InvestorsObserver gives to Tango Therapeutics Inc (TNGX) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 97 percent of stocks in the Biotechnology industry, TNGX’s 81 overall rating means the stock scores better than 81 percent of all stocks.

Overall Score - 81
TNGX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on TNGX!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Tango Therapeutics Inc Stock Today?

Tango Therapeutics Inc (TNGX) stock has fallen -13.18% while the S&P 500 is higher by 0.08% as of 1:29 PM on Monday, Oct 9. TNGX is lower by -$1.50 from the previous closing price of $11.38 on volume of 1,424,925 shares. Over the past year the S&P 500 has gained 19.37% while TNGX is higher by 142.75%. TNGX lost -$1.21 per share the over the last 12 months. Click Here to get the full Stock Report for Tango Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App